Veterinary Medicines

GALLIMUNE 403 ND+IB+IBD+REO, injekcinė emulsija

Not authorised
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bursal disease virus, strain VNJO, Inactivated
  • Avian reovirus, strain S1133, Inactivated
Download as PDF

Product identification

Medicine name:
GALLIMUNE 403 ND+IB+IBD+REO, injekcinė emulsija
Active substance:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bursal disease virus, strain VNJO, Inactivated
  • Avian reovirus, strain S1133, Inactivated
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    100000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5011870.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain VNJO, Inactivated
    501187.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Avian reovirus, strain S1133, Inactivated
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA16
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Surrendered
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/99/1006/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/12/2022
Download